Navigation Links
Alexza Pharmaceuticals Announces Upcoming Conference Participation and Webcasts
Date:11/11/2008

MOUNTAIN VIEW, Calif., Nov. 11 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced that company President and CEO Thomas B. King will present at the following investor conferences in November and December:

Lazard Capital Markets 5th Annual Healthcare Conference

The St. Regis Hotel

2 East 55th Street, New York

Presentation: Tuesday, November 18, 2008 at 5:10 p.m. ET

20th Annual Piper Jaffray Health Care Conference

The New York Palace Hotel

455 Madison Avenue, New York

Presentation: Tuesday, December 2, 2008 at 9:30 a.m. ET

RBC Capital Markets 2008 Healthcare Conference

The Westin Times Square Hotel

270 West 43rd Street, New York

Presentation: Wednesday, December 10, 2008 at 8:00 a.m. ET

A live webcast of each presentation can be accessed via the Investor Relations section of the Alexza website, at http://www.alexza.com. A replay of each webcast will be available on the website approximately 24 hours after the live presentation and will be archived for 14 days.

About Alexza Pharmaceuticals

Alexza Pharmaceuticals is an emerging specialty pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions. The Company's technology, the Staccato(R) system, vaporizes unformulated drug to form a condensation aerosol that allows rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient c
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates
2. Alexza to Announce 2008 Third Quarter Financial Results and Update Its Clinical Pipeline on Thursday, November 6, 2008
3. Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations
4. Jeffrey S. Williams Rejoins Alexza Pharmaceuticals as President, Alexza Singapore Pte. Ltd.
5. Carlos A. Parra Joins Alexza Pharmaceuticals as Vice President, Quality
6. Alexzas Corporate Presentation to be Webcast at the Seventh Annual JMP Securities Research Conference and the 2008 Citi Investment Research Global Healthcare Conference
7. Alexza to Webcast Investor and Analyst Day Presentations
8. Alexza Secures $50 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd.
9. Alexzas Corporate Presentation to be Webcast at the Cowen & Company 28th Annual Health Care Conference
10. Alexza and Autoliv Announce Commercial Manufacturing and Supply Agreement for Heat Packages Used in Single-Dose Staccato(R) System
11. Alexza to Initiate the First Phase 3 Trial for AZ-004 (Staccato(R) Loxapine) in Late Q1 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...RNewswire/ -- Three decades ago, a study revealed ...y children, prompting a switch by U.S. manufacture...e annual meeting of the Radiological Society of No...ll potentially unsafe. ,, "One of the driving f...tion in the U.S. was to eliminate inadvertent swal...
(Date:11/30/2009)..., Nov. 30 Raleigh dentist Robert...ed a new plan to educate the community and patient...,, Through a series of free educational videos ... lead role in educating the public about the benef... sedation dental care educational videos are avail...
(Date:11/30/2009)...f patients who undergo abdominal/pelvic computed t... additional image acquisition resulting in excess,...y presented today at the annual meeting of the Rad... is the responsibility of all physicians who work ...is as low as reasonably achievable without comprom...
(Date:11/29/2009)...ncer in Europe show a steady decline in mortality ...s from all cancers in the European Union (EU) betw...and eight percent in women, with a large drop amon...ished online in the cancer journal, Annals of Onc... found that there was an average 185.2 deaths per ...
(Date:11/29/2009)...cademy of General Dentistry (AGD) announces that A... Mastership Award during the AGD,s commencement ce...to excellence in dental education.,To accomplish ... continuing dental education in the 16 disciplines...nds-on skills and techniques. , ...
Breaking Medicine News(10 mins):Health News:Beverage Can Stay-Tabs Pose Swallowing Risk 2Health News:Raleigh Dentist Dr. Robert Williamson to Educate Patients About Sedation Dentistry 2Health News:Unindicated CT series result in unnecessary radiation exposure for patients 2Health News:Unindicated CT series result in unnecessary radiation exposure for patients 3Health News:New figures on cancer in Europe show a steady decline in mortality but big variations 2Health News:New figures on cancer in Europe show a steady decline in mortality but big variations 3Health News:New figures on cancer in Europe show a steady decline in mortality but big variations 4Health News:New figures on cancer in Europe show a steady decline in mortality but big variations 5Health News:Orange County Dentist Honored by The Academy of General Dentistry 2
... they might add to traditional risk factors , ...le of four offbeat biomarkers accurately predicted...a study of older Swedish men, researchers report. ...shed risk factors such as high blood pressure and ...
... Ore., May 14 On Sunday, June 29,2008, West Coast...f,Oregon,s (ALAO) Reach the Bridge Run, Portland,s...ticipants choose their own start times, but must r...the,paved roads of Forest Park., West Coast Bank ...
...y 14 /PRNewswire-FirstCall/ - LMS Medical Systems ...veloper of the CALM(R) patient,safety software sys...ults,for Fiscal 2008 (March 31), which saw a subst...y year over year. For F08,revenue totaled $4.92 mi...
... (OTCBB: IVME; Frankfurt: I7VF), INVERNESS, SCOTL...,successful balance sheet restructuring for IVMD I... commercialize its existing technology platform an...partners for the,Company,s newly developed digital...
...Serves as a One-Stop Resource for Healthcare Profe...careful research,planning and development, Onward ...der specializing in travel nursing jobs and allied...nificant improvements, resulting from extensive us...
...petite Controller, Hits U.S. Market, WAYNE, N.J.,...l of their appetite and eat up to 30 percent less ...dietary supplement that offers the,breakthrough Eu... is poised to help stop weight gain and break the,...
Other Medicine News:Health News:Biomarkers Predict Heart Deaths 2Health News:Biomarkers Predict Heart Deaths 3Health News:LMS Medical Sees Fiscal 2008 Revenue Jump 72% Over F07 - Q4/F08 Revenue Hits New Record 2Health News:IVMD Inc. kicks off new commercialization initiative 2Health News:IVMD Inc. kicks off new commercialization initiative 3Health News:Onward Healthcare Launches Enhanced Website for Travel Healthcare Professionals 2Health News:New Supplement Helps Americans Eat Less Every Day 2
(Date:11/30/2009)... , ATLANTA, Georgi...ge of,Direct Support (CDS), an internet-based curr...d in partnership by MC Strategies/Elsevier and the... Center, announced today that,its second Disabilit...w,available for administrators and learners to use...
(Date:11/29/2009)... , CHICAGO, Nov. 30 Elastograp...n added to breast ultrasound, helps distinguish ca...ing to an ongoing study presented today at the ann...merica (RSNA). ,, When mammography yields suspi... obtain additional information. However, ultrasoun...
(Date:11/29/2009)... , IOWA CITY, Iowa and ST. LOUIS, Nov. 29 /...er of quantitative imaging software for the advanc...al Technologies, a leader in minimally invasive de...nced the companies have signed a definitive agreem... an endobronchial lung navigation and biopsy syste...
Breaking Medicine Technology:Cerebral Palsy Course Strengthens CDS Curriculum as Second Disability Intensive Course Offering 2Cerebral Palsy Course Strengthens CDS Curriculum as Second Disability Intensive Course Offering 3Elastography Reduces Unnecessary Breast Biopsies 2Elastography Reduces Unnecessary Breast Biopsies 3VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 2VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 3VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 4Police work undermines cardiovascular health comparison to general population shows 50430 1Police work undermines cardiovascular health comparison to general population shows 50430 2Police work undermines cardiovascular health comparison to general population shows 50430 3Caregivers may benefit from adult day care 50428 1Caregivers may benefit from adult day care 50428 2University of Leicester researchers discover new fluorescent silicon nanoparticles 9073 1University of Leicester researchers discover new fluorescent silicon nanoparticles 9073 2
... in Remission at One Year Mainta...ay 21 Results from an,open-label extension study ...nstrate that adult moderate-to-severe Crohn,s pati...long-term clinical remission and clinical,response...day at Digestive,Disease Week(R) (DDW) in San Dieg...
...e Menopause show significant, improvement in vagi...ent symptoms associated with vulvovagi...rmaceuticals today,announced further positive data...ifene tablets) to treat postmenopausal women with ...on associated with menopause. In,January 2008, Qua...
Other Medicine Technology:Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 2Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 3Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 4Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 5Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 6Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 7QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena(TM) (Ospemifene) Phase 3 Study for Treatment of Symptoms of Vulvovaginal Atrophy 2QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena(TM) (Ospemifene) Phase 3 Study for Treatment of Symptoms of Vulvovaginal Atrophy 3
OES BF-3C40 Bronchoscope
...ull-featured bronchofiberscope yet. The BF-3C40's ...0.2mm from the previous model. It also offers bett...s, thanks to the use of extra-fine optical fibers ...by 70 percent. Images are clearer, bigger, and vir...
...e first in a series of bronchofiberscopes with ele...es necessary to meet the demand for expanded bronc...e scope includes a new control section and ergonom.... It also provides a wider field of view, a smalle...
Broncho-Cath® Endobronchial Tube with CPAP System
Medicine Products: